carbamates has been researched along with Diabetes Mellitus, Type 1 in 5 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes." | 2.69 | Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers. ( Hatorp, V; Oliver, S; Su, CA, 1998) |
| "Type 2 diabetes mellitus is a chronic disease with potentially devastating long-term complications." | 1.33 | Oral agents in managing diabetes mellitus in children and adolescents. ( Jacobson-Dickman, E; Levitsky, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Østergård, T | 1 |
| Degn, KB | 1 |
| Gall, MA | 1 |
| Carr, RD | 1 |
| Veldhuis, JD | 1 |
| Thomsen, MK | 1 |
| Rizza, RA | 1 |
| Schmitz, O | 1 |
| Ionescu-Tîrgovişte, C | 1 |
| Guja, C | 1 |
| Ioacără, S | 1 |
| Dumitrescu, D | 1 |
| Tomescu, I | 1 |
| Jacobson-Dickman, E | 1 |
| Levitsky, L | 1 |
| Hatorp, V | 1 |
| Oliver, S | 1 |
| Su, CA | 1 |
| Chowdhury, TA | 1 |
| Lasker, SS | 1 |
2 trials available for carbamates and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucago | 2004 |
Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Carbamates; Cros | 1998 |
3 other studies available for carbamates and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Continuous glucose monitoring: physiologic and pathophysiologic significance.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Circadian R | 2004 |
Oral agents in managing diabetes mellitus in children and adolescents.
Topics: Administration, Oral; Adolescent; Carbamates; Child; Clinical Trials as Topic; Diabetes Mellitus, Ty | 2005 |
Subclinical type 1 diabetes.
Topics: Adult; Blood Glucose; Carbamates; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Humans; | 2002 |